BLEVF - Beleave Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
0.0801
+0.0051 (+6.80%)
At close: 3:51PM EST
Stock chart is not supported by your current browser
Previous Close0.0750
Open0.0000
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.0000 - 0.0000
52 Week Range
Volume0
Avg. Volume633,949
Market Cap37.718M
Beta (3Y Monthly)4.36
PE Ratio (TTM)N/A
EPS (TTM)-0.0740
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • PR Newswire3 days ago

    CORRECTION - Beleave Announces GMP Certification and Operational Updates

    Please note that the below is a corrected version of the news release previously disseminated December 13th at 5pm. Beleave Inc. has advised that changes were made to the third and fourth paragraphs. TORONTO, Dec. 13, 2018 /PRNewswire/ - Beleave Inc. (BE.CN) (BLEVF) ("Beleave" or the "Company") is pleased to announce that, following a detailed application and inspection process, it has received its Good Manufacturing Practices ("GMP") certification. HACCP/GMP certification is part of the quality assurance that ensures that cannabis is consistently produced and controlled in a specific way to meet the quality standards appropriate to its intended use.

  • CNW Group3 days ago

    CORRECTION - Beleave Announces GMP Certification and Operational Updates

    Please note that the below is a corrected version of the news release previously disseminated December 13 th at 5pm . Beleave Inc. has advised that changes were made to the third and fourth paragraphs. TORONTO , Dec. 13, 2018 /CNW/ - Beleave Inc. (BE.CN) (BLEVF) ("Beleave" or the "Company") is pleased to announce that, following a detailed application and inspection process, it has received its Good Manufacturing Practices ("GMP") certification. HACCP/GMP certification is part of the quality assurance that ensures that cannabis is consistently produced and controlled in a specific way to meet the quality standards appropriate to its intended use.

  • PR Newswire3 days ago

    Beleave Announces GMP Certification and Operational Updates

    TORONTO, Dec. 13, 2018 /PRNewswire/ - Beleave Inc. (BE.CN) (BLEVF) ("Beleave" or the "Company") is pleased to announce that, following a detailed application and inspection process, it has received its Good Manufacturing Practices ("GMP") certification. HACCP/GMP certification is part of the quality assurance that ensures that cannabis is consistently produced and controlled in a specific way to meet the quality standards appropriate to its intended use. This certification solidifies the practices the Company has been perfecting in relation to product development and it demonstrates our commitment to food safety and hygiene.

  • CNW Group3 days ago

    Beleave Announces GMP Certification and Operational Updates

    TORONTO , Dec. 13, 2018 /CNW/ - Beleave Inc. (BE.CN) (BLEVF) ("Beleave" or the "Company") is pleased to announce that, following a detailed application and inspection process, it has received its Good Manufacturing Practices ("GMP") certification. HACCP/GMP certification is part of the quality assurance that ensures that cannabis is consistently produced and controlled in a specific way to meet the quality standards appropriate to its intended use. This certification solidifies the practices the Company has been perfecting in relation to product development and it demonstrates our commitment to food safety and hygiene.

  • PR Newswire17 days ago

    Beleave Announces Second Quarter of 2018 Results

    TORONTO, Nov. 29, 2018 /PRNewswire/ - Beleave Inc. (BE.CN) (BLEVF) ("Beleave" or the "Company") announces today the release of its Interim Condensed Consolidated Financial Statements for the second quarter ended September 30, 2018, together with its Management, Discussion and Analysis ("MD&A"). All values in this news release and the Company's financial disclosures are in Canadian dollars unless otherwise stated. The Company had revenues of $315,617 that didn't include recreational sales that began in October, however it was an improvement over last quarter's revenues of $208,617.

  • CNW Group17 days ago

    Beleave Announces Second Quarter of 2018 Results

    TORONTO , Nov. 29, 2018 /CNW/ - Beleave Inc. (BE.CN) (BLEVF) ("Beleave" or the "Company") announces today the release of its Interim Condensed Consolidated Financial Statements for the second quarter ended September 30, 2018 , together with its Management, Discussion and Analysis ("MD&A"). All values in this news release and the Company's financial disclosures are in Canadian dollars unless otherwise stated. The Company had revenues of $315,617 that didn't include recreational sales that began in October, however it was an improvement over last quarter's revenues of $208,617 .

  • PR Newswire20 days ago

    /R E P E A T -- Beleave Announces Release Date of Second Quarter 2018 Results and Conference Call/

    TORONTO, Nov. 23, 2018 /PRNewswire/ - Beleave Inc. (BE.CN) (BLEVF) ("Beleave" or the "Company") announces that its second quarter 2018 results will be released after market on Thursday, November 29, 2018 and will be followed by the Company's first ever conference call on Friday, November 30, 2018 at 11:00 a.m. (Eastern Time). The call will be hosted by Andrew T. Wnek, Chairman and CEO, Bojan Krasic, President and CFO and select members of the senior management team. The November corporate presentation will be available on the Company's website prior to the call, which can be accessed at www.beleave.com.

  • CNW Group20 days ago

    /R E P E A T -- Beleave Announces Release Date of Second Quarter 2018 Results and Conference Call/

    TORONTO , Nov. 23, 2018 /CNW/ - Beleave Inc. (BE.CN) (BLEVF) ("Beleave" or the "Company") announces that its second quarter 2018 results will be released after market on Thursday, November 29, 2018 and will be followed by the Company's first ever conference call on Friday, November 30, 2018 at 11:00 a.m. (Eastern Time) . The call will be hosted by Andrew T. Wnek , Chairman and CEO, Bojan Krasic , President and CFO and select members of the senior management team. The November corporate presentation will be available on the Company's website prior to the call, which can be accessed at www.beleave.com.

  • CNW Group24 days ago

    Beleave Announces Release Date of Second Quarter 2018 Results and Conference Call

    TORONTO , Nov. 23, 2018 /CNW/ - Beleave Inc. (BE.CN) (BLEVF) ("Beleave" or the "Company") announces that its second quarter 2018 results will be released after market on Thursday, November 29, 2018 and will be followed by the Company's first ever conference call on Friday, November 30, 2018 at 11:00 a.m. (Eastern Time) . The November corporate presentation will be available on the Company's website prior to the call, which can be accessed at www.beleave.com.

  • PR Newswire24 days ago

    Beleave Announces Release Date of Second Quarter 2018 Results and Conference Call

    TORONTO, Nov. 23, 2018 /PRNewswire/ - Beleave Inc. (BE.CN) (BLEVF) ("Beleave" or the "Company") announces that its second quarter 2018 results will be released after market on Thursday, November 29, 2018 and will be followed by the Company's first ever conference call on Friday, November 30, 2018 at 11:00 a.m. (Eastern Time). The November corporate presentation will be available on the Company's website prior to the call, which can be accessed at www.beleave.com.

  • CNW Grouplast month

    Beleave Announces Development of Cannabis-Infused Powder and Sugar Products for the Recreational Market

    TORONTO , Nov. 15, 2018 /CNW/ - Beleave Inc. (BE.CN) (BLEVF) ("Beleave" or the "Company") is pleased to announce that it has developed water-soluble cannabis-infused powder and sugar products to prepare for the adult recreational cannabis-infused food and beverage market next year. Beleave's Hamilton laboratory is being expanded to make room for methods to formulate cannabis extracts into soluble, flavourless powders, sugar crystals, and syrups for use in beverages and food products using stability-enhancing techniques for prolonged shelf-life. The final product offered to consumers will be a flexible, food-grade ingredient that delivers an accurate dose of THC and CBD when ingested orally, and with enhanced bioavailability.

  • PR Newswirelast month

    Beleave Announces Development of Cannabis-Infused Powder and Sugar Products for the Recreational Market

    TORONTO, Nov. 15, 2018 /PRNewswire/ - Beleave Inc. (BE.CN) (BLEVF) ("Beleave" or the "Company") is pleased to announce that it has developed water-soluble cannabis-infused powder and sugar products to prepare for the adult recreational cannabis-infused food and beverage market next year. Beleave's Hamilton laboratory is being expanded to make room for methods to formulate cannabis extracts into soluble, flavourless powders, sugar crystals, and syrups for use in beverages and food products using stability-enhancing techniques for prolonged shelf-life. The final product offered to consumers will be a flexible, food-grade ingredient that delivers an accurate dose of THC and CBD when ingested orally, and with enhanced bioavailability.

  • CNW Grouplast month

    Beleave Introduces 90 New Cannabis Varieties as it Secures Genetics Acquisition Agreements

    TORONTO , Nov. 12, 2018 /CNW/ - Beleave Inc. (BE.CN) (BLEVF) ("Beleave" or the "Company") is pleased to announce that it has secured genetics acquisition agreements for a broad range of cannabis seed varieties from diverse lineages. Last week, Health Canada notified the Company that their existing license under the ACMPR had been updated for the new system reflecting the changes under the Cannabis Act. In the coming months, Beleave will be completing construction and upgrades on new facilities in Ontario and British Columbia .

  • PR Newswirelast month

    Beleave Introduces 90 New Cannabis Varieties as it Secures Genetics Acquisition Agreements

    TORONTO, Nov. 12, 2018 /PRNewswire/ - Beleave Inc. (BE.CN) (BLEVF) ("Beleave" or the "Company") is pleased to announce that it has secured genetics acquisition agreements for a broad range of cannabis seed varieties from diverse lineages. Last week, Health Canada notified the Company that their existing license under the ACMPR had been updated for the new system reflecting the changes under the Cannabis Act. In the coming months, Beleave will be completing construction and upgrades on new facilities in Ontario and British Columbia.

  • CNW Grouplast month

    Beleave Announces Strategic Alliance Agreement with Rollins Group to Open and Operate Cannabis Retail Stores Across Canada

    TORONTO , Nov. 9, 2018 /CNW/ - Beleave Inc. (BE.CN) (BLEVF) ("Beleave" or the "Company") is pleased to announce it has entered into a Strategic Alliance Agreement (the "Agreement") with the Rollins Group Inc. ("Rollins") to open and operate cannabis retail stores across Canada . Rollins will apply for cannabis retail sales licenses across the country to open and operate cannabis retail stores. Beleave is supporting Rollins to secure lease covenants for all planned locations.

  • PR Newswirelast month

    Beleave Announces Strategic Alliance Agreement with Rollins Group to Open and Operate Cannabis Retail Stores Across Canada

    TORONTO, Nov. 9, 2018 /PRNewswire/ - Beleave Inc. (BE.CN) (BLEVF) ("Beleave" or the "Company") is pleased to announce it has entered into a Strategic Alliance Agreement (the "Agreement") with the Rollins Group Inc. ("Rollins") to open and operate cannabis retail stores across Canada. Rollins will apply for cannabis retail sales licenses across the country to open and operate cannabis retail stores.

  • CNW Grouplast month

    Beleave Announces Seven-for-One Share Split

    TORONTO , Nov. 5, 2018 /CNW/ - Beleave Inc. (BE.CN) (BLEVF) ("Beleave" or the "Company") is pleased to announce a seven-for-one share split of the Company's issued and outstanding common shares (the "Share Split"). Each shareholder of record of the Company as of the close of business on the Record Date will receive six additional shares for each share held on such date. This stock split will increase liquidity, allowing more investors to buy and sell our shares as we continue our ambitious expansion into 2019," said Andy Wnek , Beleave CEO.

  • PR Newswirelast month

    Beleave Announces Seven-for-One Share Split

    TORONTO, Nov. 5, 2018 /PRNewswire/ - Beleave Inc. (BE.CN) (BLEVF) ("Beleave" or the "Company") is pleased to announce a seven-for-one share split of the Company's issued and outstanding common shares (the "Share Split"). Each shareholder of record of the Company as of the close of business on the Record Date will receive six additional shares for each share held on such date. This stock split will increase liquidity, allowing more investors to buy and sell our shares as we continue our ambitious expansion into 2019," said Andy Wnek, Beleave CEO.

  • CNW Group2 months ago

    Beleave Penetrates European Cannabis Market through Strategic Partnership and Adds VP International Sales

    TORONTO , Oct. 29, 2018 /CNW/ - Beleave Inc. (BE.CN) (BLEVF) ("Beleave" or the "Company") is pleased to announce that it has signed an agreement with Canymed GmbH ("Canymed") to supply the German market with medical cannabis. This move is the first of a series of strategic initiatives to penetrate the robust European cannabis market and marks the Company's expansion into its third continent alongside both North and South America . "Medical cannabis has been legal in Germany since March 2017 and the country has quickly become one of the world's largest federally-regulated medical cannabis markets.

  • PR Newswire2 months ago

    Beleave Penetrates European Cannabis Market through Strategic Partnership and Adds VP International Sales

    TORONTO, Oct. 29, 2018 /PRNewswire/ - Beleave Inc. (BE.CN) (BLEVF) ("Beleave" or the "Company") is pleased to announce that it has signed an agreement with Canymed GmbH ("Canymed") to supply the German market with medical cannabis. This move is the first of a series of strategic initiatives to penetrate the robust European cannabis market and marks the Company's expansion into its third continent alongside both North and South America. "Medical cannabis has been legal in Germany since March 2017 and the country has quickly become one of the world's largest federally-regulated medical cannabis markets.

  • PR Newswire2 months ago

    Kevin Keagan Joins Beleave as Chief Communications Officer

    TORONTO, Oct. 24, 2018 /PRNewswire/ - Beleave Inc. (BE.CN) (BLEVF) ("Beleave" or the "Company") is pleased to announce that Kevin Keagan has joined the Company as Chief Communications Officer, and a member of the Executive Team. Mr. Keagan brings his extensive experience, with over 25 years in capital markets, working within the financial services industry to provide oversight to the operation, expansion, and direction of Beleave's communications and capital markets initiatives. As the Company prepares for exciting announcements in the next year, Mr. Keagan will provide valuable strategic guidance to support the Company's growth and development in the burgeoning cannabis industry.

  • CNW Group2 months ago

    Kevin Keagan Joins Beleave as Chief Communications Officer

    Kevin Keagan Joins Beleave as Chief Communications Officer

  • CNW Group2 months ago

    Beleave's Statement on Historic Day for Cannabis in Canada

    TORONTO , Oct. 17, 2018 /CNW/ - Beleave Inc. (BE.CN) (BLEVF) ("Beleave" or the "Company") would like to recognize the steadfastness, bravery, and leadership of the Canadian government, as well as other pioneers in the community who have worked tirelessly for years, to bring this day to pass. Starting today, for the first time in almost a century, cannabis will be legal for adult recreational use in Canada as we become the first G7 country to remove laws restricting its use. History will record this as a breakthrough for personal freedom and reaffirm Canada's global position as a compassionate and progressive nation to live and work.

  • PR Newswire2 months ago

    Beleave's Statement on Historic Day for Cannabis in Canada

    TORONTO, Oct. 17, 2018 /PRNewswire/ - Beleave Inc. (BE.CN) (BLEVF) ("Beleave" or the "Company") would like to recognize the steadfastness, bravery, and leadership of the Canadian government, as well as other pioneers in the community who have worked tirelessly for years, to bring this day to pass. Starting today, for the first time in almost a century, cannabis will be legal for adult recreational use in Canada as we become the first G7 country to remove laws restricting its use. History will record this as a breakthrough for personal freedom and reaffirm Canada's global position as a compassionate and progressive nation to live and work.

  • CNW Group3 months ago

    Beleave Provides Update on B.C. Indoor Facilities

    TORONTO , Oct 1, 2018 /CNW/ - Beleave Inc. (BE.CN) (BLEVF) ("Beleave" or the "Company") is pleased to announce that it is has filed an application with Health Canada and, once approved, is ready to proceed with phase one in Chilliwack of the its recently-announced indoor cultivation cannabis project in British Columbia . Less than two weeks ago, the Company announced the ambitious new project, jointly-designed by Beleave and Kannavis Biotech Corp., on a 50/50 operating expenditure and revenue partnership, that will encompass a total of ten indoor growing facilities approximately 87,000 square feet each. This project is fully capitalized and will carry newest products including strains of cannabis not yet offered in Canada , as well processing of newly acquired and developed products that will include edibles, drinks, and other non-combustible cannabis products that Beleave will be releasing to the general public in the near future.